Transplantační medicína

Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
^{Miyoshi H et al. Diabetes Ther. 2023;14(4):671-689.}